SYRE
Spyre Therapeutics Inc.
$24.46
+$0.20(+0.82%)
52
Overall
60
Value
66
Tech
31
Quality
Market Cap
$959.77M
Volume
683.32K
52W Range
$10.91 - $40.26
Target Price
$52.91
Key Metrics Overview
| Market Cap | $959.77M | P/E Ratio | N/A |
| 52W High | $40.26 | 52W Low | $10.91 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | 0.0% | 52W Position | 46.2% |
| Overall Score | 52 | Value Score | 60 |
| Quality Score | 31 | Technical Score | 66 |
Growth Analysis
| EPS Current Est | $-2.6 | EPS Next Est | $-3.06 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SYRE | $24.46 | +0.8% | 683.32K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |